Risk factors for nonadherence to warfarin: Results from the IN-RANGE study

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 9, 2008, Pages 853-860

  Platt, Alec B ^a   Localio, A Russell ^a,b   Brensinger, Colleen M ^a   Cruess, Dean G ^c   Christie, Jason D ^a   Gross, Robert ^a,b,d   Parker, Catherine S ^e   Price, Maureen ^a   Metlay, Joshua P ^a,b,d   Cohen, Abigail ^a   Newcomb, Craig W ^a   Strom, Brian L ^a,b   Laskin, Mitchell S ^f   Kimmel, Stephen E ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anticoagulation; Medication adherence; MEMS; Warfarin

Indexed keywords

WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULATION; ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MENTAL HEALTH; MULTICENTER STUDY; PATIENT COMPLIANCE; PILL; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RETIREMENT; RISK FACTOR; UNEMPLOYMENT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MEDICATION ERRORS; MENTAL HEALTH; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RISK FACTORS; SOCIOECONOMIC FACTORS; WARFARIN;

EID: 52949151490     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1556     Document Type: Article

References (28)

1. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004; 126: 204S-233S.
2. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154: 1449-1457.
3. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. The European Atrial Fibrillation Trial Study Group. N Engl J Med 1995; 333: 5-10.
4. Kimmel SE, Chen Z, Price M, et al. The influence of patient adherence on anticoagulation control with warfarin: results from the international normalized ratio adherence and genetics (IN-RANGE) study. Arch Intern Med 2007; 167: 229-235.
5. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897-902.
6. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S-21S.
7. Wittkowsky AK, Devine EB. Frequency and causes of over-anticoagulation and underanticoagulation in patients treated with warfatin. Pharmacotherapy 2004; 24: 1311-1316.
8. Palareti G, Legnani C, Guazzaloca G, et al. Risks factors for highly unstable response to oral anticoagulation: a case-control study. Br J Haematol 2005; 129: 72-78.
9. Kealey C, Chen Z, Christie J, et al. Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity. Pharmacogenomics 2007; 8: 217-225.
10. Waterman AD, Milligan PE, Bayer L, et al. Effect of warfarin nonadherence on control of the international normalized ratio. Am J Health Syst Pharm 2004; 61: 1258-1264.
11. Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19: 357-362.
12. Wang PS, Bohn RL, Knight E, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17: 504-511.
13. Nunes MI. The relationship between quality of life and adherence to treatment. Curr Hypertens Rep 2001; 3: 462-465.
14. Parker CS, Chen Z, Price M, et al. Adherence to warfarin assessed by electronic pill caps, clinician assessment, and patient reports: results from the IN-RANGE study. J Gen Intern Med 2007; 22: 1254-1259.
15. Gross R, Bilker WB, Friedman RM, et al. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS 2002; 16: 1835-1837.
16. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846-857.
17. Medical Expenditure Panel Survey (MEPS) FAMES Panel 1 Round 2 Access to Care (AC) Section 15 February 1998, p. 26-2. Available at http://www.meps.ahrq.gov/mepsweb/survey_comp/survey-questionnaires.jsp [26 November 2007].
18. Ware JE, Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
19. Jacobs JW, Bernhard MR, Delgado A, et al. Screening for organic mental syndromes in the medically ill. Ann Intern Med 1977; 86: 40-46.
20. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401.
21. Pepe MS, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlation response data. Communications in Statistics Simulation & Computation 1994; 23: 939-951.
22. Sun GW, Shook TL, Kay GL. Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 1996; 49: 907-916.
23. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. American Journal of Gastroenterology 2007; 120: 1417-1426.
24. Arnsten JH, Gelfand JM, Singer DE. Determinants of compliance with anticoagulation: a case-control study. Am J Med 1997; 103: 11-17.
25. Trachtenberg F, Dugan E, Hall MA. How patients' trust relates to their involvement in medical care. J Fam Pract 2005; 54: 344-352.
26. Schillinger D, Wang F, Rodriguez M, et al. The importance of establishing regimen concordance in preventing medication errors in anticoagulant care. J Health Commun 2006; 11: 555-567.
27. Nikolaus T, Kruse W, Bach M, et al. Elderly patients' problems with medication. An in-hospital and follow-up study. Eur J Clin Pharmacol 1996; 49: 255-259.
28. Kulkarni SP, Alexander KP, Lytle B, et al. Long-term adherence with cardiovascular drug regimens. Am Heart J 2006; 151: 185-191.